Industry Pioneers Break New Ground with Patent Highlighting Efficacy of BioCell Collagen II® for Joint and Skin Health
NEWPORT BEACH, CA, September 27, 2004 - BioCell Technology, LLC, exclusive worldwide supplier of BioCell Collagen II®, was recently awarded a patent for the manufacturing process of BioCell Collagen II®, hydrolyzed collagen type II with hyaluronic acid (HA) and chondroitin sulfate. The U.S. patent supports the joint, skin, and eye health benefit research findings for their pioneering invention of collagen type II and further establishes the company's leadership role in the natural products and cosmecuticals industries. Already the recipient of two previous patents, the new patent includes novel methods and compositions containing hyaluronic acid, which is a powerful and essential ingredient in the collagen matrix.
"BioCell has worked diligently to provide consumers with the highest concentrated natural source of collagen type II available in the marketplace today. Our advanced ingredient and manufacturing process is supported by credible scientific research. As our third patent, we are confident that it will protect our innovative technology and further validate the quality of BioCell Collagen II® and the ingredient's efficacy for joint and skin health benefits," said Suhail Ishaq, vice president of BioCell Technology, LLC.
The United States Patent and Trademark Office awarded Patent No. US 6,780,841, entitled hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same to BioCell on August 24, 2004. The patent protects BioCell's process of manufacturing, preparation and use of hydrolzyed collagen type II powder compositions
administered orally for absorption through the gastrointestinal tract or topically for dermis absorption in treating connective tissue disorder and replenishing skin viscoelasticity.
BioCell Collagen II® is a natural type II collagen ingredient that provides a naturally occurring matrix of bioavailable Hyaluronic Acid, depolymerized Chondroitin Sulfate, and Collagen Type II. The new patent protects the composition of BioCell Collagen II®, the natural matrix that matches the joint structure itself, in both oral and topical applications. Synergistically, BioCell Collagen II® may be the missing link to glucosomine and chondroitin formula combinations.
According to Ishaq, the patent highlights many of the ingredient's joint health benefits. Hydrolyzed collagen type II can be used to treat degenerative joint diseases like rheumatoid arthritis and osteoarthritis, joint defects, vascular disease, progressive myopia, cartilage injuries and connective tissue disorders that usually benefit from increased synthesis of new cartilage. BioCell Collagen II® is the most abundant protein found in joint cartilage and reduces oxidative damage to the joints. Hyaluronic acid (HA) is a joint nourishing element that is essential in reducing joint friction caused by the joint's degradation of its natural lubrication.
Collagen type II skin health benefits are also widely recognized. Since BioCell Collagen II® is of low molecular weight, research has shown that this is easily absorbed and readily available for use in the body. HA acts as a skin-nourishing element that allows skin to retain moisture, which promotes healing and skin tissue rejuvenation. The revitalizing constituents of the HA and chondroitin sulfate work together to restore viscoelasticity to the skin, reduce sun-induced wrinkles, protect connective tissues, promote cartilage synthesis, heal wounds and improve the overall appearance of the skin.
Ishaq said BioCell is preparing to advance information on the new patent and details on increased scientific findings in support of BioCell Collagen II® at the SupplySide West International Trade Show and Conference in Las Vegas next month. On Friday, October 1 Dr. William V. Judy will present a special educational seminar titled "BioCell Collagen II® Bioavailable Collagen & Hyaluronic Acid: New Science on Skin and Joint Health Benefits" at 2 p.m. -2:50 p.m. in Room 801-802 in Venetian & Sands Expo. For more information on this innovative ingredient and the patent visit www.biocelltechnology.com.
Founded in 1997, BioCell Technology, LLC pioneered the applications of Sternum Collagen Type II, the highest concentrated natural source available of type II collagen. It is the exclusive supplier of BioCell Collagen II®. BioCell Technology, LLC owns the exclusive rights to market BioCell Collagen II® under the United States Patent #6,025,327. BioCell Collagen II® is a branded registered logo that is available for display on its client's labels to market under their own brand name or formulas. For more information on BioCell Collagen II®, please contact Asma Ishaq at BioCell Technology, LLC at (714) 632-1231, or visit them at www.biocelltechnology.com .